Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECHNOLOGY
BIOCON LTD.
Biocon Ltd.
NSE: BIOCON | BSE: 532523
Mid-range Performer
Download real time
369.20
0.80
(
0.22
%)
26.87% Gain from 52W Low
14.4M
NSE+BSE Volume
High volume today
NSE
19 Sep, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
BUY STOCK
US FDA Approval
Biocon's arm gets US FDA approval for Bosaya and Aukelso injections with a market size of $5 bn
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(4)
About
Biocon Ltd. News, Corporate filings and Earnings/Conference Calls
Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.
All
News
Earnings Calls
Corporate Announcements
Research Reports
Load latest
Is Biocon Ltd. worth buying?
727 Votes:
Buy
74.97%
Sell
16.37%
Hold
8.67%
BUY
SELL
HOLD
RESEARCH REPORTS
Buy
SEE REPORTS >
11 Aug 2025
pdf
Biocon Ltd.
by Axis Direct
| Target:
380
| Upside:
2.93%
Sell
SEE REPORTS >
09 Aug 2025
pdf
Biocon Ltd.
by ICICI Securities Limited
| Target:
270
| Upside:
26.87%
All reports of BIOCON